Table 3.
Efficacy
| Participants free of active rabies infection, no. (%) | |
| At day 14 | 30 (100) |
| At day 84 | 30 (100) |
| RVNA titer | |
| No. of participants with RVNA titer ≥0.5 IU/mL at day 14 | 28 (93.3) |
| Mean ± SD | 18.89 ± 31.61 |
| Median | 8.81 |
| Range (min – max) | 0.21–153.62 |
Percentages are based on the number of participants in the as-treated population. RVNA titers denote the geometric mean of the results per participant per visit.27
min – max, minimum to maximum; RVNA, rabies virus neutralizing antibody; SD, standard deviation.